Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc

Iovance Biotherapeutics Inc Price Chart IOVA

Historical daily share price chart and data for Iovance Biotherapeutics Inc since 2010 adjusted for splits and dividends. The latest closing price for Iovance Biotherapeutics Inc as of December 01, 2020 is $41.32.
  • In 2020 the stock opened at $27.96 and closed at $41.32 for a gain of 32% YTD.
  • In 2019 the stock opened at $8.77 and closed at $27.68 for a gain of 68%.
  • In 2018 the stock opened at $8.10 and closed at $8.85 for a gain of 8%.
  • In 2017 the stock opened at $7.10 and closed at $8.00 for a gain of 11%.
View Chart On Koyfin

Iovance Biotherapeutics Inc Summary

Stock Symbol: IOVA

Iovance Biotherapeutics Inc Company Info

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company’s lead product candidates include lifileucel that is in Phase II clinical trial for the treatment of metastatic melanoma; and LN-145 for the treatment of metastatic cervical cancer. It is also developing tumor infiltrating lymphocytes (TIL) and peripheral blood lymphocyte therapies for the treatment of squamous cell carcinoma of the head and neck, non-small cell lung cancer, and chronic lymphocytic leukemia through its sponsored trials, as well as in other oncology indications through collaborations. Iovance Biotherapeutics, Inc. has collaboration agreements with Moffitt, M.D. Anderson Cancer Center, Ohio State University, and MedImmune; and research collaboration with Cellectis S.A. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was founded in 2007 and is headquartered in San Carlos, California.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
1657.04 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of IOVA Prices